HRQoL was assessed using the 30-item core European Organization for the Research and Treatment of Cancer ( EORTC ) Quality-of-Life Questionnaire ( EORTC QLQ-C30 ) at baseline and at weeks 4 , 8 , and 12 in patients who received treatment on protocol .